| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-2571-8 | 71335-2571 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20250205 | N/A | ANDA | ANDA218122 | Bryant Ranch Prepack | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 9 CAPSULE in 1 BOTTLE (71335-2571-8) |
| 71335-2571-9 | 71335-2571 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20250205 | N/A | ANDA | ANDA218122 | Bryant Ranch Prepack | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 5 CAPSULE in 1 BOTTLE (71335-2571-9) |
| 67296-2172-1 | 67296-2172 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20230905 | N/A | ANDA | ANDA218122 | Redpharm Drug | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 15 CAPSULE in 1 BOTTLE (67296-2172-1) |
| 59651-691-01 | 59651-691 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20230905 | N/A | ANDA | ANDA218122 | Aurobindo Pharma Limited | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (59651-691-01) |
| 59651-691-05 | 59651-691 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20230905 | N/A | ANDA | ANDA218122 | Aurobindo Pharma Limited | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 500 CAPSULE in 1 BOTTLE (59651-691-05) |